XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Conduct a value analysis of cash back cards with no fees to make smart financial choices. Understand the benefits and options available.
25,276 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Urban Outfitters’ namesake stores are lifting results as fourth-quarter earnings beat expectations, signaling a broad...
Oscar week brings glamour and guarded budgets alike. This guide shows you how to spot the signals, plan your spending...
Elon Musk announced a Texas-based Terafab chip initiative, a joint venture between TESLA and SPACE X, to build advanc...
Vornado Realty Trust CEO Steven Roth used a quarterly earnings call to harshly rebuke New York City's tax agenda, cal...
A three-way push for space-based AI puts Elon Musk and Jeff Bezos in a high-stakes orbit with a rising rival coalitio...
In 2026, seniors leveraging a paid-off $1.4 million home are turning to reverse mortgages to shore up retirement inco...
A high-net-worth retiree with a $2.2 million traditional IRA confronts a $7,400 annual Medicare surcharge as Required...
Global equities fell as AI-driven rally fizzled and investors watched for signs of a SpaceX IPO. The move underscored...
As AI workloads spur hyperscale data-center expansion, Vertiv’s order book signals a durable cycle that could lift th...
Palantir tumbles about 7% midday as Palo Alto Networks and CrowdStrike hold steadier, raising questions about governm...
A high-earning professional contemplates paying off his ex-wife’s house after divorce, prompting a broader debate: sh...